• Korean Chemical Engineering Research
• /
• 제53권4호
• /
• pp.472-477
• /
• 2015

본 연구에서는 패러데이 모트를 사용한 기존의 피코리터 주입용 미세유체 칩에 은 나노입자를 이용한 전극을 추가하여 전압을 낮추며 효율을 높이는 실험을 수행하였다. 먼저, 복잡한 제조공정에서 탈피하여 은 나노입자 용액을 한 방울 떨어뜨리는 간단한 과정만으로 미세유체 피코리터 주입기 내에 전극을 제조하였다. 본 개념을 통한 은 나노입자 전극과 패러데이 모트가 통합된 미세유체 칩은 은 나노입자 전극을 사용하지 않는 기존 미세유체 칩의 피코리터 주입 시작 전압인 260 V 보다 낮은 전압인 180 V에서 피코리터 주입이 작동되었다. 또한 미세유체 피코리터 주입기는 피코리터 주입 부피를 7.5 pL부터 27.5 pL까지 정밀하게 조절할 수 있음을 주된 장점으로 하고 있다. 본 미세유체 피코리터 주입기는 미세유체 시스템의 새로운 기능을 설계함으로써 각 연구분야를 탐구할 유용한 플랫폼으로 기대되고 있다.

• BMB Reports
• /
• 제40권1호
• /
• pp.119-124
• /
• 2007

Adenoviral vectors are among the most promising vectors available for human gene therapy. However, the use of recombinant adenoviral vectors, including replicationcompetent adenovirus (RCA), raises a variety of safety concerns in relation to the development of new therapies based on gene therapy. To examine how organic compounds change in rat plasma following the injection of adenovirus, $\beta$-galactosidase expressing recombinant adenovirus (designated rAdLacZ) or RCA, we investigated the content of fatty acids (FAs), which are important biochemical indicators in pathological conditions. Pattern recognition analysis on the level of FAs in rat plasma is described for the visual discrimination of adenovirus infection groups from normal controls. Plasma FAs from four control rats (normal group), and from four rats with rAdLacZ infection and six rats with RCA infection (the two abnormal groups), were examined by gas chromatography-mass spectrometry in selected ion monitoring modes as their tert-butyldimethylsilyl derivatives. In total, 20 FAs were positively detected and quantified. The results of the Student's t-test on the normal mean of two abnormal groups, the levels of three FAs (p<0.05) from rAdLacZ group and eleven FAs (p<0.05) from RCA group were significantly different. When star symbol plotting was applied to the group mean values of 20 FAs after normalization to the corresponding normal mean values, the resulting eicosagonal star patterns of the two infected groups were distorted into similar shapes, but were distinguishable from each other. Thus, these approaches will be useful for screening and monitoring of diagnostic markers for the effects of infection following the use of adenoviral vectors in gene therapy.

• 한국정보통신학회:학술대회논문집
• /
• 한국해양정보통신학회 2011년도 추계학술대회
• /
• pp.331-334
• /
• 2011

본 연구는 근육의 기능을 조절하는 신경말단에 전기적인 자극을 가하여 신경의 반응 정도를 측정하는 플랫폼 구현에 관란 연구로써, 전기 자극에 대한 신경반응이 가해지는 전류량, 가해진느 전류지속시간, 전극위치에 따른 반응을 측정하였다. 신경자극의 전극 위치는 표면 말단에 운동신경이면 어느 신경이든지 가능하고, 신경자극 양식에는 단순연축자극, 사연속자극, 두 집단 발사자극이 있다. 임베디드 시스템기반으로 가기위한 저전력 MCU를 선정하고, 기본적인 신경자극반응 측정 센서의 민감도를 알아보기 위해 센서 인터페이스를 구성하여 반응정도를 측정해야 한다. 그리고 측정된 Data의 정확도를 높이기 위해 고성능의 AD Convertor 선정하여 플랫폼을 구현하였다. 또한 본 논문의 플랫폼은 의료기기용으로 개발되었기 때문에 시스템 이용자의 안전을 고려하여 전원회로 구성 시 전원 Isolation를 고려하여 설계하였다.

• 대한한방부인과학회지
• /
• 제24권2호
• /
• pp.68-78
• /
• 2011

Objectives: The purpose of this study is to analyze the perception that women in 20s and 30s have on Traditional Korean Medical(TKM) treatment on the leukorrhea. Methods: We studied the perception of TKM treatment by questionnaire From October 1 to November 20, 2010. A questionnaire was given to 50 women and we studied 47 except 3 questionnaire which have inappropriate answer. Results: 1. In 47 women, 46(97.9%) women have heard about leukorrhea, 1(2.1%) woman hasn't heard about it. 2. In 32 women who suffered from the leukorrhea, 14(43.8%) women checked up for leukorrhea. 18(56.2%) women doesn't checked. 10 of 14 women took the medical treatment (drug or injection) and 2 of 14 women took the TKM treatment. 3. In 32 women, 16(50.0%) women know about TKM treatment for leukorrhea, 16(50.0%) women don't know. 4. In 32 women, 20(62.5%) women have intention of TKM treatment for leukorrhea, 2(6.2%) women don't have, and 10(31.3%) women don't know. The biggest obstacle was the high cost of TKM treatment. Conclusions: Many women are willing to take TKM treatment on the leukorrhea. We need more accumulation of data for demonstrating the efficacy and safety of TKM treatment.

• 한국가금학회지
• /
• 제42권3호
• /
• pp.239-245
• /
• 2015

Transgenic animals have been widely used for developmental biology studies, as disease models, and even in industry such as transgenic bioreactor animals. For transgenic birds, quail has the great advantages of small body size, short generation time, and frequent egg production. To date, retroviral or lentiviral transduction has been used to generate transgenic quail for various purposes. However, the efficiency of transgenic offspring production with these methods is relatively low and viral vector usage has safety issues. Unfortunately, non-viral transgenesis has not been established in quail due to a deficiency of stem cell and germ cell culture systems. In this study, we established a direct in ovo lipofection method that could be used to create transgenic quail without germline-competent cells or viruses. To optimize the injection stage during embryo development, the liposome complex (containing piggyBacCMV-GFP and transposase plasmids) was introduced into an embryonic blood vessel at 50 hr, 55 hr or 60 hr. GFP expression was detected in various tissues (heart, kidney, liver and stomach) on day 12 of incubation under a fluorescence microscope. Additionally, GFP-positive cells were detected in the recipient embryonic gonads. In conclusion, the direct in ovo lipofection method with the piggyBac transposon could be an efficient and useful tool for generating transgenic quail.

• International Journal of Industrial Entomology and Biomaterials
• /
• 제20권2호
• /
• pp.75-77
• /
• 2010

Until now, the main treatment for impotence has been the vasodilator injection, penile implants and etc. Among many methods, most effective way is known to be the medical therapy. The oral drug for an impotence remedy has to be above all, effective to the erection, and second, safety when taking in long-term. However, so far the drug in such condition and sufficiency has not been discovered. Consequently, it is crucial to develop the new medicine, made of natural materials only, without any uncertainty of side effect. The silkworm is very difference in physiological chemical change according to growth stage. Therefore the functional effect shows a very big difference according to preparation method with a growth stage. This research carry out the experiment with the pupa powder immediately before the eclosion, eclosion adult, the pupa extract immediately before the eclosion, and the silkworm powder of 5 instar 3rd day. The result showed not a big chance in weight, feed and water intake quantity. But testosterone hormone secretion effects of the freeze drying powder of the pupa immediately before the eclosion was very high 7.31 ng/ml, compared to 2.37 ng/ml of non treatment and 2.67 ng/ml of alcohol extraction method. As this result, the freeze drying pupa powder of the pupa immediately before the eclosion was confirmed to promote the secretion of the testosterone hormone more than alcohol extraction method of existing.

• 터널과지하공간
• /
• 제18권2호
• /
• pp.125-133
• /
• 2008

본 고에서는 파쇄대가 존재하는 기반암 상부에 지하차도를 계획하는 경우, 하부지반의 지지력 증대 및 침하량 감소 목적으로 적용할 수 있는 기초 보강공법에 대하여 연구하였다. 보강효과 및 적정 설치간격을 수치해석적으로 예측함으로써 실제 시공시 기초자료로 활용할 수 있도록 하였다. 이를 위해, 충청남도 연기군 지역에서 수행된 시추조사, 물리탐사 및 실내 실험결과 등을 분석하여 그 결과로부터 파쇄대의 물리적, 역학적특성을 파악하고 지하차도의 지내력을 확보할 수 있는 효과적인 보강대책을 검토하였다. 아울러, 보강사례에서 조사된 공법들 중 이중관 고압분사 공법, 삼중관 고압분사 공법, 마이크로 파일 등의 적정 보강심도를 선정하였으며, 수치해석(Plaxis 8.2 프로그램)을 통해 설치간격 등을 변화시켜가면서 동일한 안정성을 기준으로 가장 효과적인 공법의 제원을 비교 검토하였다.

• Biomolecules & Therapeutics
• /
• 제3권4호
• /
• pp.316-321
• /
• 1995

All the pharmacological studies of LB17522 described here were carried out with high doses (fifteen to sixty times of the therapeutic dose) to determine an indication of potential side effects in clinical use in terms of the acute clinical signs, cardiovascular and central nervous system. LB10522 does not produce any observable clinical signs except for the symptoms such as moist eye, skin rash, slight salivation, vomitting, and slightly reduced activity. The effects of LB10522 on the hemodynamics and cardiac function of anesthetized beagle dogs are as follows; heart rates and mean arterial blood pressure had a tendency to increase mildly, which is a normal finding in anesthetized dogs. All the animals except for one showed relatively stable respiratory rates throughout the observation period. Each animal treated with LB10522 showed slight increase in the left cardiac work and left ventricular stroke work which are mainly related to corresponding increases in cardiac output. Femoral blood flow were shown to be increased in some animals treated with LB10522. The epileptogenic activities of various cephalosporins were assessed by a direct intracerebral injection of appropriate concentration of test articles. The CD$_{50}$ values (nmol) obtained from the analysis of the dose-response data are as follows; 78.2, 175.3, 156.3, and 53.5 for cefazolin, cephaloridine, ceftazidime, and LB 10522, respectively. LB10522 seems to be equipotent with cefazolin or to be three times more potent than cephaloridine and ceftazidime in causing adverse CNS stimulation. Taken into consideration all the information obtained, LB10522 is not supposed to induce much changes in the functions examined in these studies in man at therapeutic doses.s.

• Biomolecules & Therapeutics
• /
• 제3권4호
• /
• pp.322-326
• /
• 1995

General pharmacology of LB20304, a quinolone antibiotic, were examined in terms of general behaviour, cardiovascular, and central nervous system. LB20304 at oral dose of 2,000 mg/kg did not induce significant behavioural changes in mice. In contrast with ciprofloxacin, LB20304 at dose of 20 mg/kg, iv. did not show any observable effects on the blood pressure in rats. Displacement of [$^3$H]muscimol binding to the rat brain synaptic membranes was measured. LB20304 was shown to be about five times less potent than ciprofloxacin in specific GABA receptor binding. Drug interaction between LB20304 and 4-biphenyl acetic acid, an active metabolite of fenbufen, was assessed in mice by measuring convulsion and/or subsequent death. A single oral pretreatment with 4-BPA at 400 mg/kg increased the incidence of convulsion and death after oral administration of ciprofloxacin at the doses of 25, 50, and 100 from zero of five to three of five, two of five, and four of five, respectively, whereas LB20304 alone or combination with 4-BPA caused neither convulsions nor death at the doses of 12.5, 25, 50, and 100 mg/kg, respectively. Quinolones-induced epileptogenic activities were assessed by a direct intracerebral injection of test articles. The CD$_{50}$ values (nmole) are as follows; 169.47, 35.36, 105.29, and 88.67 for LB20304, ciprofloxacin, of loxacin, and lomefloxacin, respectively. From these data, LB 20304 at therapeutic doses seems to be much more safe than any other quinolones tested.d.

• 방사선산업학회지
• /
• 제11권1호
• /
• pp.19-25
• /
• 2017

It is suggested that the dose limit recommended in the Enforcement Decree of Korea's Nuclear Safety Act should not exceed 150 mSv per year for radiation workers. Recently, however, ICRP 118 report has suggested that the threshold dose of the lens should be reduced to 0.2~0.5 Gy and the mean dose should not exceed 50 mSv per year for an average of 20 mSv over 5 years. Based on these contents, $^{123}I$, $^{99m}Tc$, and $^{18}F-FDG$, which are radioisotope drugs that are used directly by radiation workers in the nuclear medicine department in Korea are expected to receive a large dose of radiation in the lens in distribution and injection jobs to administer them to patients. The ED3 Active Extremity Dosimeter was used to measure the dose of the lens in the nuclear medicine and radiation workers and how much of the dose was received per 1 mCi.